Latest Articles
Endometrial cancer surge in young women linked to obesity - UCI Health
Endometrial cancer surge in young women linked to obesity UCI Health
Published: Oct. 17, 2024, 11:29 p.m.
Endometrial Cancer Market: Trends in Diagnosis, Treatment - openPR
Endometrial Cancer Market: Trends in Diagnosis, Treatment openPR
Published: Oct. 17, 2024, 2:30 p.m.
Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin - Nature.com
Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin Nature.com
Published: Oct. 16, 2024, 2:34 p.m.
Precision Surgical Technique Enables Lymph Node Detection and Removal in Endometrial Cancer - HospiMedica
Precision Surgical Technique Enables Lymph Node Detection and Removal in Endometrial Cancer HospiMedica
Published: Oct. 15, 2024, 4:36 p.m.
Endometrial Cancer Market Size, Share, Growth Insights and Report 2024-2031 | Pfizer, AbilityPharma, Eisai Co Ltd - openPR
Endometrial Cancer Market Size, Share, Growth Insights and Report 2024-2031 | Pfizer, AbilityPharma, Eisai Co Ltd openPR
Published: Oct. 15, 2024, 12:47 p.m.
New Innovations in Endometrial Cancer Market Technology: - openPR
New Innovations in Endometrial Cancer Market Technology: openPR
Published: Oct. 14, 2024, 12:16 p.m.
Progestin-based pharmacotherapy in fertility preservation in early endometrial cancer：A Minireview - Frontiers
Progestin-based pharmacotherapy in fertility preservation in early endometrial cancer：A Minireview Frontiers
Published: Oct. 14, 2024, 11:09 a.m.
Ultrasound Screening Often Misses Endometrial Cancer in Black Females - Healthline
Ultrasound Screening Often Misses Endometrial Cancer in Black Females Healthline
Published: July 9, 2024, 7 a.m.
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - Medpage Today
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer Medpage Today
Published: July 5, 2024, 7 a.m.
Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer - OncLive
Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer OncLive
Published: July 3, 2024, 7 a.m.
Link copied to clipboard!